Education
About Us
Working with TipRanks
Follow Us
Intelligent Bio Solutions Inc. (INBS)
:INBS
RESEARCH TOOLSreports
INBS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $3.28
Previous CloseN/A
Volume32.28K
Average Volume (3M)125.73K
Market Cap
$8.65M
Enterprise Value$3.26M
Total Cash (Recent Filing)$18.07K
Total Debt (Recent Filing)$5.13M
Price to Earnings (P/E)―
Beta2.25
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.44
Shares Outstanding6,811,578
10 Day Avg. Volume82,689
30 Day Avg. Volume125,726
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.76
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.38
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.29
Enterprise Value/Ebitda-0.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Intelligent Bio Solutions News
PremiumCompany Announcements
Intelligent Bio Solutions Secures U.S. Patent for Drug Screening
PremiumCompany Announcements
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval---
Ownership Overview
3.09% Insiders
0.61% Mutual Funds
0.15% Other Institutional Investors
95.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
INBS FAQ
What was Intelligent Bio Solutions Inc.’s price range in the past 12 months?
Intelligent Bio Solutions Inc. lowest stock price was $1.00 and its highest was $3.28 in the past 12 months.
What is Intelligent Bio Solutions Inc.’s market cap?
Intelligent Bio Solutions Inc.’s market cap is $8.65M.
When is Intelligent Bio Solutions Inc.’s upcoming earnings report date?
Intelligent Bio Solutions Inc.’s upcoming earnings report date is May 07, 2025 which is in 21 days.
How were Intelligent Bio Solutions Inc.’s earnings last quarter?
Currently, no data Available
Is Intelligent Bio Solutions Inc. overvalued?
According to Wall Street analysts Intelligent Bio Solutions Inc.’s price is currently Overvalued.
Does Intelligent Bio Solutions Inc. pay dividends?
Intelligent Bio Solutions Inc. does not currently pay dividends.
What is Intelligent Bio Solutions Inc.’s EPS estimate?
Intelligent Bio Solutions Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intelligent Bio Solutions Inc. have?
Intelligent Bio Solutions Inc. has 6,811,578 shares outstanding.
What happened to Intelligent Bio Solutions Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Intelligent Bio Solutions Inc.?
Currently, no hedge funds are holding shares in INBS
---
Company Description
Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
---
Technical Analysis
---